Find real-time BLU - BELLUS Health Inc stock quotes, company profile, news and forecasts from CNN Business. Laval, Quebec Canada H7V 4A7 Tel. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. About Us. Actions of Bellus Health (NASDAQ: BLU) (TSX: BLU) were down 69.2% at 2:40 p.m. EST Monday after it announced that a phase 2 trial of BLU-5937 as a treatment for chronic refractory cough has missed its target.. The day’s price range saw the stock hit a low of $3.89, while the highest price level was $4.18. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Current stock quote for BELLUS Health Inc. ( BLU ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion Stock Chart. ... BELLUS Health Inc. 275 Armand-Frappier Blvd. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Bellus Health Inc () Stock Market info Recommendations: Buy or sell Blumerang Investors S.A. stock? Get the latest BELLUS Health Inc. (BLU) stock news and headlines to help you in your trading and investing decisions. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. BELLUS Health Inc (BLU) has risen Tuesday morning, with the stock rising 8.09% in pre-market trading to 4.01. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. 4.03 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) ... BELLUS Health (NASDAQ:BLU) Intraday Stock Chart Tuesday 2 March 2021 Your Recent History LSE. Source: Kantar Media. UKX FTSE 100 LSE. BLU's short-term technical score of 9 indicates that the stock has traded less bullishly over the last month than 91% of stocks on the market. Information about the BELLUS Health Inc. Stock. U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.78% By Investing.com - Jul 06, 2020. In the Biotechnology industry, which ranks 88 out of 146 ind Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. What happened. Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. Copyright 2019© FactSet Research Systems Inc. All rights reserved. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. How has BELLUS Health's share price performed over time and what events caused price changes? Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Latest news headlines for Bellus Health Inc with market analysis and analyst commentary. Committed to Addressing Chronic Disorders Triggered by Hypersensitization Including Chronic Cough. Stock Quote & Chart Stock Quote. BELLUS Health (NASDAQ:BLU) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday, Zacks.com reports. Real time BELLUS Health Inc. (BLU) stock price quote, stock graph, news & analysis. Data Provided by Refinitiv. Stock analysis for BELLUS Health Inc (BLU:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. Minimum 15 minutes delayed. BLU, Bellus Health Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Bellus Health Inc Stock Quote: BLU Stock News, Quotes, Analysis | Investors.com Shares of Bellus Health were falling 69.2% at 2:40 p.m. EST on Monday following its announcement that a phase 2 trial of BLU-5937 as a treatment for refractory chronic cough has missed its … BELLUS Health (BLU) stock price, charts, trades & the US's most popular discussion forums. The increase is primarily attributable to the Company’s increased workforce in 2020 as well as to higher stock-based compensation expense in relation to BELLUS Health’s stock option plan. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Strong day for BELLUS Health Inc. stock price on Monday rising 5.63% to $5.07 (Updated on March 01, 2021) Buy or Hold candidate since 2021-02-01 Gain 10.70% PDF . ... BELLUS Health Inc. News. BLU | Complete BELLUS Health Inc. stock news by MarketWatch. According to Zacks, “BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs. BELLUS Health Inc. [NASDAQ: BLU] closed the trading session at $4.18 on 03/03/21. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. About BELLUS Health (www.bellushealth.com) BELLUS Health is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. The company’s stock price has collected 5.03% of gains in the last five trading sessions. Latest Share Price and Events Stable Share Price : BLU is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Feb 25. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Furthermore, BELLUS Health Inc. (BLU)’s beta value is 0.51, and its average true range (ATR) is 0.4. The stock has traded between $3.33 and $3.62 so … Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. The company report on February 26, 2021 that BELLUS Health Reports … BELLUS Health Inc. (NASDAQ:BLU) went up by 7.46% from its latest closing price compared to the recent 1-year high of $12.03. Yahoo fait partie de Verizon Media. This page features the latest news about the BELLUS Health Inc. stock. News. Get the latest BELLUS HEALTH INC. (BLU.TO) stock news and headlines to help you in your trading and investing decisions. View real-time stock prices and stock quotes for a full financial overview. The Company's product candidate, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus. Get BELLUS Health Inc (BLU:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. GKP Gulf Keyst.. LSE. BELLUS Health (BLU): FY GAAP EPS of -$0.54 misses by $0.01.Revenue of $15kCash, cash equivalents and short-term investments of $98.3M.Press Release In comparing BELLUS Health Inc. (BLU)’s stock with other industry players reveals that stock’s current price change of -1.01% and that of -54.51% over the past 12 months is in competing position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price fell by -3.12% in the last trading and went through a decline of -4.82% in past 12-month trading. Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. QPP Quindell FTSE. Fundamental company data and analyst estimates provided by FactSet. Since then, BLU shares have decreased by 57.1% and is now trading at $4.03. So what. The BELLUS Health Inc. stock price gained 5.63% on the last trading day (Monday, 1st Mar 2021), rising from $4.80 to $5.07.During the day the stock fluctuated 8.42% from a day low at $4.75 to a day high of $5.15. Get BELLUS Health Inc (BHN0-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. BELLUS Health Inc (BLU) stock is trading at $3.62 as of 11:51 AM on Monday, Feb 1, a rise of $0.39, or 12.07% from the previous closing price of $3.23. View More. View the latest BELLUS Health Inc. (BLU) stock price, news, historical charts, analyst ratings and financial information from WSJ. The company’s stock has been forecasted to trade at an average price of $7.32 over the course of the next 52 weeks, with a low of $2.6 and a high of $12. Today's High Today's Low 52 Week High 52 Week Low. BRIEF-Bellus Health Establishes At-The-Market Facility By Reuters - Dec 23, 2020. Get the latest BELLUS Health (BLU) stock price quote with real-time news, financials, charts and other important investing information. ... Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Data may be intentionally delayed pursuant to supplier requirements. International stock quotes are delayed as per exchange requirements. BLU is not currently paying a regular dividend. Source: FactSet. Follow BLU. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. Stock Information. Free forex prices, toplists, indices and lots more. BELLUS Health News . Get news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public. BELLUS Health's stock was trading at $9.40 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Press Release reported on 02/25/21 that BELLUS Health Reports Year 2020 Financial Results and Business Highlights. Bellus Health shares are trading higher after RBC Capital initiated coverage on the stock with an Outperform rating and a price target of $8 per share. If the company raises additional capital, the stock dilution could exist, … Find the latest BELLUS HEALTH INC. (BLU.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. All rights reserved. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Change Volume Today's Open Previous Close. BLU Bellus Health Inc Latest News. As said, BELLUS Health will need additional financing to continue its operations.